SCHEMBL8401424

SCHEMBL8401424

CCOP(=O)(COCCOC(C)=O)OCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
TSHR P16473 3/20 0.59
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PPARD Q03181 1/20 0.39
THRB P10828 1/20 0.39
CHRM5 P08912 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
PGR P06401 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
HTR1A P08908 1/20 0.35
CHRNB2 P17787 1/20 0.35
TBXA2R P21731 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16463538 0.89 ALDH1A1 (0.47) ALDH1A1TSHRLMNAHSD17B10PPARD
SCHEMBL14622514 0.87 ALDH1A1 (0.52) ALDH1A1TSHRLMNAHSD17B10THRB
SCHEMBL8939174 0.84 ALDH1A1 (0.57) ALDH1A1TSHRLMNAHSD17B10PPARD
SCHEMBL8764430 0.82 ALDH1A1 (0.50) ALDH1A1TSHRLMNAHSD17B10PPARD
SCHEMBL9304075 0.82 TSHR (0.52) ALDH1A1TSHRLMNAPPARDSMN1; SMN2
SCHEMBL10497259 0.81 TSHR (0.53) ALDH1A1TSHRLMNAHSD17B10PPARD
SCHEMBL8397081 0.79 TSHR (0.41) ALDH1A1TSHRPPARDCA12CA1
SCHEMBL751991 0.79 PPARD (0.54) ALDH1A1TSHRLMNAHSD17B10PPARD
SCHEMBL28994311 0.78 TSHR (0.48) ALDH1A1TSHRPPARDSMN1; SMN2GAA
Ammonia Solution, Strong SCHEMBL28851800 0.77 PPARD (0.52) ALDH1A1TSHRLMNAHSD17B10PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903994-B1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-22 EP disclosed
US-9738766-B2 Organophosphorus compounds for flame retardant polyurethane foams DOW GLOBAL TECHNOLOGIES LLC (US) 2017-08-22 US disclosed
US-20150274915-A1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES LLC (US) 2015-10-01 US disclosed
EP-2903994-A1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS Dow Global Technologies LLC (US) 2015-08-12 EP disclosed
WO-2014056138-A1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-04-17 WO disclosed
US-5874577-A Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof MEDICHEM RESEARCH, INC. (US) 1999-02-23 US disclosed
US-5854228-A Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 1998-12-29 US disclosed
US-5650510-A VIRICIDES OR ANTITUMOR AGENTS INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 1997-07-22 US disclosed
EP-0269947-B2 Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives ACAD OF SCIENCE CZECH REPUBLIC (CS) 1996-10-16 EP disclosed
EP-0319228-B1 Novel compounds BEECHAM GROUP PLC (GB) 1994-11-02 EP disclosed
US-5247085-A Phosphonate containing purine compounds BEECHAM GROUP P.L.C. (GB) 1993-09-21 US disclosed
EP-0269947-A1 Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) 1988-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274915-A1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS PFAS, FGR, FFAR3 ALDH1A1 3561/4885TSHR 267/4885LMNA 4596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.